Xcout IntelBIOREGENX, INC.
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
Subscribe to see BIOREGENX, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BIOREGENX, INC. at a glance
BIOREGENX, INC. is a medical - diagnostics & research company headquartered in Chattanooga, United States. It is publicly listed (BRGX) with a market capitalisation of $7.3M. Xcout tracks 12 named people at BIOREGENX, INC., including William Resides (CEO, Interim CFO, Chairman, & Executive Director).
BIOREGENX, INC. leadership
- William ResidesCEO, Interim CFO, Chairman, & Executive Director
- Diane BouisActing Chief Executive Officer MVHS
- Gary HennerbergSecretary
- Gary HennerbergDirector
- Gary KissDirector
- Jody Marie WalkerDirector
6 more named people on record for BIOREGENX, INC., with roles, board committees and tenure — see the full roster →
BIOREGENX, INC. competitors
A few of BIOREGENX, INC.'s closest competitors — see the full list of competitors and alternatives →
NX Prenatal Inc. is a private US-based molecular diagnostics and medical device company with corporate offices in Houston, Texas, and Lexington, Kentucky. It specializes in biomarker-based tests for women’s health and pregnancy outcomes.
Established in 1998 and headquartered in Taipei, Taiwan, PhytoHealth Corporation specializes in the research, development, production, and commercialization of a diverse portfolio including pharmaceutical products, cosmetic lines, specific over-the-counter medications (Class B), and nutritional supplements. Their prominent offerings feature the PG2 Lyophilized injection, specifically designed to alleviate cancer-related fatigue. The company also markets EnerCharge, available both as a formula to boost physical vigor and maintain mental alertness, and as an energy beverage. Another notable product is ReyeasCleanse health food capsules. Furthermore, PhytoHealth extends its expertise to precision medical devices, specialized diagnostic software, and licensing services for computer-aided diagnostic systems.
i-calQ Corp. develops medical and diagnostic technology products, including cortisol and TSH tests, as well as a mobile app and ProReader. The company provides these diagnostic solutions and products to its customers.
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Biolimitless Centers of Excellence, Inc. provides self-care and longevity products, including precision testing kits, science-backed nutritional supplements, and peptide formulas. The company also offers educational resources, courses, and AI-powered technologies to help individuals understand their genetic and cellular health.
Get BIOREGENX, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BIOREGENX, INC. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access